These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17187574)

  • 1. Dissociation between inhibition and killing by levofloxacin in human granulocytic anaplasmosis.
    Wormser GP; Filozov A; Telford SR; Utpat S; Kamer RS; Liveris D; Wang G; Zentmaier L; Schwartz I; Aguero-Rosenfeld ME
    Vector Borne Zoonotic Dis; 2006; 6(4):388-94. PubMed ID: 17187574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and control of human granulocytic anaplasmosis: a systematic review.
    Jin H; Wei F; Liu Q; Qian J
    Vector Borne Zoonotic Dis; 2012 Apr; 12(4):269-74. PubMed ID: 22217177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human granulocytic anaplasmosis.
    Bakken JS; Dumler S
    Infect Dis Clin North Am; 2008 Sep; 22(3):433-48, viii. PubMed ID: 18755383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review on the eco-epidemiology and clinical management of human granulocytic anaplasmosis and its agent in Europe.
    Matei IA; Estrada-Peña A; Cutler SJ; Vayssier-Taussat M; Varela-Castro L; Potkonjak A; Zeller H; Mihalca AD
    Parasit Vectors; 2019 Dec; 12(1):599. PubMed ID: 31864403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCR2 blockade influences Anaplasma phagocytophilum propagation but not histopathology in the mouse model of human granulocytic anaplasmosis.
    Scorpio DG; Akkoyunlu M; Fikrig E; Dumler JS
    Clin Diagn Lab Immunol; 2004 Sep; 11(5):963-8. PubMed ID: 15358660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate immune tissue injury and murine HGA: tissue injury in the murine model of granulocytic anaplasmosis relates to host innate immune response and not pathogen load.
    Scorpio DG; Von Loewenich FD; Bogdan C; Dumler JS
    Ann N Y Acad Sci; 2005 Dec; 1063():425-8. PubMed ID: 16481553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anaplasma phagocytophilum presenting with orchitis in a renal transplant recipient.
    Khatri A; Lloji A; Doobay R; Wang G; Knoll B; Dhand A; Nog R
    Transpl Infect Dis; 2019 Aug; 21(4):e13129. PubMed ID: 31215144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular diagnosis of human granulocytic anaplasmosis.
    Dumler JS; Brouqui P
    Expert Rev Mol Diagn; 2004 Jul; 4(4):559-69. PubMed ID: 15225103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical diagnosis and treatment of human granulocytotropic anaplasmosis.
    Bakken JS; Dumler JS
    Ann N Y Acad Sci; 2006 Oct; 1078():236-47. PubMed ID: 17114714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological, clinical, and laboratory characteristics of human granulocytic anaplasmosis in North India.
    Vinayaraj EV; Thakur CK; Negi P; Sreenath K; Upadhyay P; Verma N; Das BK; Kabra SK; Wig N; Chaudhry R
    J Clin Microbiol; 2024 Mar; 62(3):e0104823. PubMed ID: 38329335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of clinical and laboratory characteristics of patients fulfilling criteria for proven and probable human granulocytic anaplasmosis.
    Lotrič-Furlan S; Rojko T; Jelovšek M; Petrovec M; Avšič-Županc T; Lusa L; Strle F
    Microbes Infect; 2015; 17(11-12):829-33. PubMed ID: 26432519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human granulocytic anaplasmosis acquired in Connecticut, USA, diagnosed in Vienna, Austria, 2015.
    Markowicz M; Schötta AM; Wijnveld M; Stanek G
    Diagn Microbiol Infect Dis; 2016 Apr; 84(4):347-9. PubMed ID: 26778486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human granulocytic anaplasmosis combined with rhabdomyolysis: a case report.
    Cho JM; Chang J; Kim DM; Kwak YG; Cho CR; Song JE
    BMC Infect Dis; 2021 Nov; 21(1):1184. PubMed ID: 34823480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Granulocytic Anaplasmosis.
    MacQueen D; Centellas F
    Infect Dis Clin North Am; 2022 Sep; 36(3):639-654. PubMed ID: 36116840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Rare Case of ARDS From Human Anaplasmosis.
    Kaphle U; Kheir F; Thammasitboon S
    Respir Care; 2015 Jul; 60(7):e125-7. PubMed ID: 25669216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human anaplasmosis in Belgium: a 10-year seroepidemiological study.
    Cochez C; Ducoffre G; Vandenvelde C; Luyasu V; Heyman P
    Ticks Tick Borne Dis; 2011 Sep; 2(3):156-9. PubMed ID: 21890069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular diagnosis of autochthonous human anaplasmosis in Austria - an infectious diseases case report.
    Hoepler W; Markowicz M; Schoetta AM; Zoufaly A; Stanek G; Wenisch C
    BMC Infect Dis; 2020 Apr; 20(1):288. PubMed ID: 32306908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manifestation of anaplasmosis as cerebral infarction: a case report.
    Kim SW; Kim CM; Kim DM; Yun NR
    BMC Infect Dis; 2018 Aug; 18(1):409. PubMed ID: 30119642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute Kidney Injury Associated With Human Granulocytic Anaplasmosis: A Case Report.
    Zhuo M; Calev H; Saunders SJ; Li J; Stillman IE; Danziger J
    Am J Kidney Dis; 2019 Nov; 74(5):696-699. PubMed ID: 31200977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional inhibition or genetic deletion of acid sphingomyelinase bacteriostatically inhibits Anaplasma phagocytophilum infection in vivo.
    Naimi WA; Gumpf JJ; Cockburn CL; Camus S; Chalfant CE; Li PL; Carlyon JA
    Pathog Dis; 2021 Jan; 79(1):. PubMed ID: 33220685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.